The Washington Center for Bleeding Disorders (WACBD) is a federally funded Hemophilia Treatment Center that was established in 1974 to provide medical care and education to all patients with inherited bleeding disorders in the State of Washington.
On 11/28/20 the operation of the WACBD moved from Bloodworks to the Washington Institute for Coagulation (WIC), a 501(c)(3) nonprofit organization with the primary purpose to provide education and care for people with inherited bleeding disorders throughout the State of Washington.
Funding for the Center is established through the Health Resources and Services Administration (HRSA), the Center for Disease Control (CDC) and our approved 340B pharmacy.
The Washington Center for Bleeding Disorders (WACBD) is dedicated to secure, promote and protect optimal health for people with bleeding disorders through comprehensive care, education and research in partnership with our patients, their families, and the local and national bleeding disorders community.
As a recognized center of excellence in comprehensive care and research for bleeding disorders, we will be the primary resource for patients, families, providers and community. We are committed to every patient in our region having access to appropriate therapies. We will work in partnership with our patients to inspire confidence and independence.